Currently, TC Biopharm (Holdings) Plc’s (TCBP) stock is trading at $0.54, marking a gain of 13.68% from last night’s close. At this price, the stock is -99.44% below its 52-week high of $96.10 and 49.34% above its 52-week low of $0.36. Based on the past 30-day period, the stock price is -4.97% below the high and +61.61% above the low.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, TCBP’s SMA-200 is $1.3507.
As well, it is important to consider TCBP stock ratios such as price-to-sales, which is currently 1.52.TCBP’s price to book ratio for the most recent quarter was 0.08, resulting in an 2.21 price to cash per share for the period.
How does TC Biopharm (Holdings) Plc (TCBP) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
TC Biopharm (Holdings) Plc (NASDAQ: TCBP) Ownership Details
I will give a breakdown of the key shareholders in TC Biopharm (Holdings) Plc (TCBP). Recent figures show that the company’s insiders hold 11.74% of shares. A total of 4 institutional investors hold shares in the company, making 5.23% of its stock and 5.93% of its float.
Jun 29, 2023, it was reported that the Company’s largest institutional holder is Armistice Capital, LLC holding total of 0.53 million shares that make 6.52% of the company’s total number of shares and are currently priced at 0.29 million.
The securities firm Citadel Advisors Llc holds 75295.0 shares of TCBP, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.93%, and the holding percentage of shares is valued at 41720.0.
An overview of TC Biopharm (Holdings) Plc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests TC Biopharm (Holdings) Plc (TCBP) traded 532,318 shares per day, with a moving average of $0.4412 and price change of +0.1344. With the moving average of $0.4210 and a price change of +0.0514, about 412,067 shares changed hands on average over the past 50 days. Finally, TCBP’s 100-day average volume is 595,695 shares, alongside a moving average of $0.4795 and a price change of -0.0175.
